Goldhaber SZ - Search Results

1

Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD-AF Registry.

Cools F, Johnson D, Camm AJ, Bassand JP, Verheugt FWA, Yang S, Tsiatis A, Fitzmaurice DA, Goldhaber SZ, Kayani G, Goto S, Haas S, Misselwitz F, Turpie AGG, Fox KAA, Pieper KS, Kakkar AK; GARFIELD-AF Investigators. Cools F, et al. Among authors: goldhaber sz. J Thromb Haemost. 2021 Sep;19(9):2322-2334. doi: 10.1111/jth.15415. Epub 2021 Jul 23. J Thromb Haemost. 2021. PMID: 34060704 Free PMC article.

2

Controversies surrounding long-term anticoagulation of very elderly patients in atrial fibrillation.

Marine JE, Goldhaber SZ. Marine JE, et al. Among authors: goldhaber sz. Chest. 1998 Apr;113(4):1115-8. doi: 10.1378/chest.113.4.1115. Chest. 1998. PMID: 9554655 Review. No abstract available.

3

Monitoring anticoagulation.

Goldhaber SZ. Goldhaber SZ. J Invasive Cardiol. 2000;12 Suppl C:11C-12C. J Invasive Cardiol. 2000. PMID: 10762862 Review. No abstract available.

4

Thrombolysis in pulmonary embolism: a debatable indication.

Goldhaber SZ. Goldhaber SZ. Thromb Haemost. 2001 Jul;86(1):444-51. Thromb Haemost. 2001. PMID: 11487035 Review.

5

Effectiveness and safety of long-term anticoagulation of patients >/=90 years of age with atrial fibrillation.

Joffe HV, Goldhaber SZ. Joffe HV, et al. Among authors: goldhaber sz. Am J Cardiol. 2002 Dec 15;90(12):1397-8. doi: 10.1016/s0002-9149(02)02883-7. Am J Cardiol. 2002. PMID: 12480055 No abstract available.

6

Enoxaparin monotherapy without oral anticoagulation to treat acute symptomatic pulmonary embolism.

Beckman JA, Dunn K, Sasahara AA, Goldhaber SZ. Beckman JA, et al. Among authors: goldhaber sz. Thromb Haemost. 2003 Jun;89(6):953-8. Thromb Haemost. 2003. PMID: 12783106 Clinical Trial.

7

Warfarin dosing and cytochrome P450 2C9 polymorphisms.

Joffe HV, Xu R, Johnson FB, Longtine J, Kucher N, Goldhaber SZ. Joffe HV, et al. Among authors: goldhaber sz. Thromb Haemost. 2004 Jun;91(6):1123-8. doi: 10.1160/TH04-02-0083. Thromb Haemost. 2004. PMID: 15175798

8

Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.

Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ; PREVENT Medical Thromboprophylaxis Study Group. Leizorovicz A, et al. Among authors: goldhaber sz. Circulation. 2004 Aug 17;110(7):874-9. doi: 10.1161/01.CIR.0000138928.83266.24. Epub 2004 Aug 2. Circulation. 2004. PMID: 15289368 Clinical Trial.

9

Prevention of venous thromboembolism among hospitalized medical patients.

Goldhaber SZ, Turpie AG. Goldhaber SZ, et al. Circulation. 2005 Jan 4;111(1):e1-3. doi: 10.1161/01.CIR.0000150393.51958.54. Circulation. 2005. PMID: 15630031 Review. No abstract available.

10

Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients.

Vaitkus PT, Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Goldhaber SZ; PREVENT Medical Thromboprophylaxis Study Group. Vaitkus PT, et al. Among authors: goldhaber sz. Thromb Haemost. 2005 Jan;93(1):76-9. doi: 10.1160/TH04-05-0323. Thromb Haemost. 2005. PMID: 15630494

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

736 results

Search Page

Filters